1. 1165PImmune checkpoint inhibitors following targeted therapies in MITF family translocation renal cell carcinomas. (18th September 2017) Authors: Boileve, A.; Carlo, M.; Barthelemy, P.; Oudard, S.; Borchiellini, D.; Voss, M.; George, S.; Chevreau, C.; Landman-Parker, J.; Tabone, M-D.; Chism, D.; Amin, A.; Bilen, M.A.; Bosse, D.; Choueiri, T.K.; Tannir, N.; Malouf, G. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1302 Outcome of elderly patients suffering from solid tumor and admitted to Intensive Care Unit (ICU). (September 2015) Authors: Auclin, E.; Oudard, S.; Guerot, E.; Thibault, C.; Klein, E.; Combe, P.; Hauw-Berlemont, C.; Diehl, J.L.; Fagon, J.Y.; Taieb, J.; Aissaoui, N. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1503 Impact of pain on survival in metastatic cancer patients treated with chemotherapy: A prospective longitudinal study of patient-reported severity. (September 2015) Authors: Elaidi, R.T.; Scotte, F.; Duong, K.; Rance, B.; Bouchouicha, A.; Fabre, E.; Medioni, J.; Oudard, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1568 Deleterious joint effect of fatigue and anemia in cancer patients treated with chemotherapy. (September 2015) Authors: Scotte, F.; Fabre, E.; Medioni, J.; Combe, P.; Angelergues, A.; Thibault, C.; Oudard, S.; Elaidi, R.T. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1582 Longitudinal study on the impact of patient-reported fatigue on survival in metastatic cancer patients treated with chemotherapy. (September 2015) Authors: Duong, K.; Fabre, E.; Scotte, F.; Medioni, J.; Rance, B.; Bouchouicha, A.; Oudard, S.; Elaidi, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 1610 Renal function in patients receiving chemotherapy: Impact on survival. (September 2015) Authors: Thibault, C.; Duong, D.K.; Scotte, F.; Rance, B.; Bouchouicha, A.; Oudard, S.; Elaidi, R.T. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 17LBA Results from an open-label, randomized, controlled Phase 3 study investigating IMA901 multipeptide cancer vaccine in patients receiving sunitinib as first-line therapy for advanced/metastatic RCC. (September 2015) Authors: Rini, B.; Stenzl, A.; Zdrojowy, R.; Kogan, M.; Shkolnik, M.; Oudard, S.; Weikert, S.; Bracarda, S.; Crabb, S.; Bedke, J.; Ludwig, J.; Maurer, D.; Mendrzyk, R.; Mahr, A.; Fritsche, J.; Weinschenk, T.; Singh, H.; Kirner, A.; Reinhardt, C.; Eisen, T. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S718 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 223 Predictive biomarkers in metastatic Renal Cell Carcinoma (mRCC) patients treated with neoadjuvant sunitinib (PREINSUT trial). (September 2015) Authors: Mauge, L.; Pereira, H.; Gille, A.S.; Bouaboula, M.; Grine, A.; Elaïdi, R.T.; Tartour, E.; Fournier, L.; Oudard, S.; Helley, D. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 2538 Response to cabazitaxel in patients with metastatic castrationresistant prostate cancer (mCRPC) poorly responding to docetaxel. (September 2015) Authors: Angelergues, A.; Bellmunt, J.; Efstathiou, E.; Gonzalez, I.; Gyftaki, R.; Delanoy, N.; Ozguroglu, M.; Flechon, A.; Guillot, A.; Le Moulec, S.; Castellano, D.; Esteban, E.; Munarriz, J.; Campos Balea, B.; Ardavanis, A.; Stefanou, D.; Oudard, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 2541 Updated results of the FLAC European database of metastatic castration resistant prostate cancer (mCRPC) patients (pts) treated with life extending therapies in post-docetaxel (D) setting. (September 2015) Authors: Oudard, S.; Angelergues, A.; Efstathiou, E.; Gonzalez, I.; Gyftaki, R.; Delanoy, N.; Ozguroglu, M.; Flechon, A.; Guillot, A.; Le Moulec, S.; Castellano, D.; Esteban, E.; Munarriz, J.; Campos Balea, B.; Ardavanis, A.; Stefanou, D.; Bellmunt, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S489 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗